pyrrolidonecarboxylic acid and Nasal Obstruction

pyrrolidonecarboxylic acid has been researched along with Nasal Obstruction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Brindisi, G; Conte, MP; De Castro, G; Duse, M; Gori, A; Leonardi, L; Marazzato, M; Schiavi, L; Zicari, AM1
Cannavò, A; Leocata, RC; Palermo, A; Patanè, C; Scatà, D; Tropi, G1

Trials

1 trial(s) available for pyrrolidonecarboxylic acid and Nasal Obstruction

ArticleYear
Efficacy of Pidotimod use in treating allergic rhinitis in a pediatric population.
    Italian journal of pediatrics, 2020, Jul-07, Volume: 46, Issue:1

    Topics: Adenoids; Age Factors; Child; Female; Humans; Hypertrophy; Immunologic Factors; Italy; Male; Nasal Obstruction; Pyrrolidonecarboxylic Acid; Rhinitis, Allergic; Thiazolidines; Treatment Outcome

2020

Other Studies

1 other study(ies) available for pyrrolidonecarboxylic acid and Nasal Obstruction

ArticleYear
Pirometaxine™ (Narlisim™) in pediatric nasal congestion: a retrospective study.
    Minerva pediatrica, 2019, Volume: 71, Issue:2

    Topics: Adolescent; Child; Child, Preschool; Common Cold; Copper Sulfate; Drug Combinations; Humans; Nasal Decongestants; Nasal Obstruction; Nasal Sprays; Pyrrolidonecarboxylic Acid; Retrospective Studies; Time Factors; Treatment Outcome

2019